Riskpilot← Back to searchSign inGet full accessEnmarks Psykoterapi AB
ABIn liquidationOrg 5568608870Other human health activities · NACE 8690Est. 20110 employees
Revenue 2024
SEK 40K
-78% vs 2023
EBITDA margin
-115.0%
-187% vs 2023
Equity ratio
72.9%
Financial strength
Net profit 2024
SEK -45K
-181% vs 2023
| Revenue | SEK 40K | -78% |
| EBITDA | SEK -46K | -187% |
| Net profit | SEK -45K | -181% |
| Total assets | SEK 107K | -14% |
| Equity | SEK 78K | -37% |
| Employees | 0 | — |
Legal name
Enmarks Psykoterapi AB
Org number
5568608870
Legal form
Aktiebolag
NACE code
8690 · Other human health activities
Founded
11 augusti 2011
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-06-30
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Aktiebolaget ska bedriva individual-, par- och familjeterapi, familjerådgivning samt psykosocial handledning och konsultation, bedriva författarverksamhet, bokutgivning, redaktionellt arbete, föreläsningar samt bedriva därmed förnelig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 73 | 53 | 141 | 179 | 40 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −27 | −82 | −11 | −16 | −46 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −27 | −82 | −11 | −16 | −46 |
| Net financials | — | — | — | — | 1 |
| Profit before tax | 0 | −55 | −11 | −16 | −45 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | −55 | −11 | −16 | −45 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 276 | 151 | 140 | 124 | 107 |
| Equity | 206 | 151 | 140 | 124 | 78 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 43 | 0 | 0 | 0 | 29 |
| Total debt | 43 | — | — | — | 29 |
EBITDA margin
-115.0%
This company
15.8%
Market median
-828% vs market
20202024
Equity ratio
72.9%
This company
38.2%
Market median
+91% vs market
20202024
Return on equity
-57.7%
This company
18.4%
Market median
-414% vs market
20202024
Net profit margin
-112.5%
This company
8.1%
Market median
-1489% vs market
20202024
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20202024
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
IA | Audit | 2022 |
MK Liquidator | Liquidator | 2024 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Enmarks Psykoterapi AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingrid Annika Bellman Asp | Audit | 0 companies |
| Maria Kristin Enmark | Liquidator | 0 companies |
| Karl Adam Enmark | Deputy Board Member | 0 companies |